Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Warfarin pharmacogenetics in a black Zimbabwean cohort: an observational prospective study.

Pharmacogenomics - 1 Jul 2023

M Hidjo Marie Madeleine, Chikwambi Zedias, Ngwende Gift, Matenga Jonathan A, Masimirembwa Collen

Abstract excerpt

Aim: A prospective observational study was conducted to evaluate the feasibility of implementing clinical guidelines for warfarin dosing in black Zimbabwean patients. Methods: CYP2C9*5, CYP2C9*6, CYP2C9*8 and CYP2C9*11 and VKORC1 c. 1639 G>A variations were observed in 62 study patients. Results & Conclusion: Overall, 39/62 (62.90%) participants did not receive a warfarin starting dose as would have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Genotype

Share to Pharmacogenetics

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Share to Zimbabwe

Source

Open in PubMed Open full text

Identifiers

PMID: 37435666
DOI: 10.2217/pgs-2023-0089
PMCID: PMC10621760

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Warfarin pharmacogenetics in a black Zimbabwean cohort: an observational prospective study.PMID 37435666Read ↗

Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm.Semantic proximity Read ↗

Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry.Semantic proximity Read ↗

Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.Semantic proximity Read ↗

Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.Semantic proximity Read ↗

CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic DosingSemantic proximity Read ↗

Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.Semantic proximity Read ↗

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and HerzegovinaSemantic proximity Read ↗

Pharmacogenomics of warfarin in populations of A frican descentSemantic proximity Read ↗

Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population.Semantic proximity Read ↗

Warfarin pharmacogenetics: polymorphisms of the CYP2C9, CYP4F2, and VKORC1 loci in a genetically admixed Omani population.Semantic proximity Read ↗

Genetic variants associated with warfarin dosage in Kuwaiti population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.